12.8.2022 18:32:54 CEST | Demant A/S |
Investor Nyheder
Investor news
12. august 2022
Sammenligningstal for 2021
Den 27. april 2022 meldte Demant ud, at man havde besluttet at afvikle sin Hearing Implants-forretning. I henhold til IFRS 5 – Anlægsaktiver bestemt for salg og ophørte aktiviteter og som tidligere meldt ud indregnes Hearing Implants derfor i koncernens finansielle rapportering og regnskab som en ophørende aktivitet, og sammenligningstallene for 2021 er justeret for at afspejle dette. Med henblik på afstemning af disse justerede tal med de rapporterede tal har vi vedhæftet justerede resultatopgørelser (ureviderede) for følgende rapporteringsperioder: H1 2021, H2 2021 og FY 2021.
Bemærk venligst, at det vedhæftede dokument kun indeholder historiske tal for at lette sammenligningen mellem historiske og fremtidige resultater.
Yderligere information:
Søren Nielsen, koncernchef og adm. direktør
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
René Schneider, CFO
Mathias Holten Møller, Head of Investor Relations
Peter Pudselykke, Investor Relations Officer
Trine Kromann-Mikkelsen, VP Corporate Communication and Relations
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
220812 Investor news – sammenligningstal for 2021.pdf
Demant – Comparative figures for 2021.xlsx
12.8.2022 18:32:54 CEST | Demant A/S |
Investor News
Investor news
12 August 2022
Comparative figures for 2021
On 27 April 2022, Demant announced the decision to discontinue its Hearing Implants business. In accordance with IFRS 5 – Non-current Assets Held for Sale and Discontinued Operations and as previously communicated, Hearing Implants is therefore recognised in the Group’s financial reporting and statements as a discontinued operation, and comparative figures for 2021 are restated to reflect this. To help reconcile such restated figures with reported figures, we attach restated income statements (unaudited) for the following reporting periods: H1 2021, H2 2021 and FY 2021.
Please note that the attachment only includes historical figures in order to ease the comparison between historical and future performance.
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Mathias Holten Møller, Head of Investor Relations
Peter Pudselykke, Investor Relations Officer
Trine Kromann-Mikkelsen, VP Corporate Communication and Relations
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
220812 Investor news – comparative figures for 2021.pdf
Demant – Comparative figures for 2021.xlsx
